Citius Pharmaceuticals Inc (CTXR)

12:50 PM

Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments - TipRanks

12:50 PM

May 15, 2025

Citius Pharmaceuticals (CTXR) Receives Continued "Buy" Rating from Analyst | CTXR Stock News - GuruFocus

May 15, 2025

May 15, 2025

Citius Pharmaceuticals (CTXR) Receives Continued "Buy" Rating fr - GuruFocus

May 15, 2025

May 14, 2025

Citius Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 - GuruFocus

May 14, 2025

May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Laun - GuruFocus

May 14, 2025

May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025

May 14, 2025

Citius Pharmaceuticals Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025

May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - WV News

May 14, 2025

May 11, 2025

Citius Pharmaceuticals (CTXR) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 09, 2025

Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR™ - Barchart.com

May 09, 2025

May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 05, 2025

May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - The Malaysian Reserve

May 05, 2025

May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | CTXR Stock News - GuruFocus

May 05, 2025

May 05, 2025

Citius Pharmaceuticals Reveals Growth Strategy at Major Jefferies Healthcare Conference - Stock Titan

May 05, 2025

May 04, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Shares Sold by Geode Capital Management LLC - Defense World

May 04, 2025

Apr 21, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.92 - Investing.com

Apr 21, 2025

Apr 21, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.92 By Investing.com - Investing.com Canada

Apr 21, 2025

Apr 12, 2025

Citius Pharmaceuticals (CTXR) Price Target Adjusted to $4 Amid S - GuruFocus

Apr 12, 2025

Apr 10, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.94 By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.94 - Investing.com Australia

Apr 10, 2025

Apr 04, 2025

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Longview News-Journal

Apr 04, 2025

Apr 02, 2025

Citius Pharmaceuticals stock plummets on $2M registered direct offering of common stock - MSN

Apr 02, 2025

Apr 01, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.21 - Investing.com

Apr 01, 2025

Apr 01, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.21 By Investing.com - Investing.com India

Apr 01, 2025

Apr 01, 2025

Citius Pharma secures $2 million in stock offering By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Citius Pharma secures $2 million in stock offering - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Citius Pharmaceuticals announces $2M registered direct offering of common stock - TipRanks

Apr 01, 2025

Mar 31, 2025

CTXR’s Stock Woes: Down -87.99% in 6 Months, Down -87.99% in Just 5 Days - investchronicle.com

Mar 31, 2025

Mar 28, 2025

IL-2s gain ground as US market heads for $4 billion by 2034 - The Pharma Letter

Mar 28, 2025

Mar 28, 2025

Analysts Expect Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) To Breakeven Soon - simplywall.st

Mar 28, 2025

Mar 25, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.45 By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.45 - Investing.com India

Mar 25, 2025

Mar 15, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near Future - simplywall.st

Mar 15, 2025

Mar 09, 2025

Fisher Asset Management LLC Acquires Shares of 12,800 Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Mar 09, 2025

Feb 24, 2025

Citius Pharma Advances LYMPHIR Launch Amid Financial Updates - TipRanks

Feb 24, 2025

Feb 21, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 21, 2025

Feb 19, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Given Buy Rating at D. Boral Capital - Defense World

Feb 19, 2025

Feb 18, 2025

Citius Pharma's LYMPHIR gains permanent J-code for billing - MSN

Feb 18, 2025

Feb 18, 2025

Citius Pharmaceuticals stock hits 52-week low at $2.43 By Investing.com - Investing.com Nigeria

Feb 18, 2025

Feb 18, 2025

Citius Pharmaceuticals stock hits 52-week low at $2.43 - Investing.com India

Feb 18, 2025